MedPath

Effect of pressure reducing effect of Ripasudil eye drops in patients with high pressure within the eye

Not Applicable
Conditions
Health Condition 1: H401- Open-angle glaucoma
Registration Number
CTRI/2022/09/045191
Lead Sponsor
Sankara eye hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Patients with Central Corneal Thickness corrected intraocular pressure more than or equal to 22mmHg which includes primary open angle glaucoma and ocular hypertension

Exclusion Criteria

Patients with history of ocular trauma

Patients with history of intraocular surgery

Secondary glaucomas like angle closure glaucoma, neovascular glaucoma, pseudo-exfoliative glaucoma, pigmentary glaucoma

Patients with pre-existing corneal diseases

Pre-existing dry eye

Patients with allergic conjunctivitis

Pregnant and lactating women

Patients who are not willing for follow up

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To study the intraocular pressure lowering effect of 0.4% Ripasudil eye drops in patients with primary open angle glaucoma and ocular hypertensionTimepoint: Intraocular pressure is measured at baseline, 4 weeks, 12 weeks and 24 weeks
Secondary Outcome Measures
NameTimeMethod
To assess the incidence of side effects with RipasudilTimepoint: By assessing the side effects at 1st month, 3rd month and 6th month;To assess the IOP lowering effect of Ripasudil as a monotherapy or as an additive agentTimepoint: By comparing IOP at presentation (baseline) and at 1st month, 3rd months, 6th months;To assess the requirement of additional lubricants to continue RipasudilTimepoint: By assessing the side effects at 1st month, 3rd month and 6th month;To assess the requirement of additional ocular hypotensive drug in those patients on Ripasudil therapyTimepoint: By comparing IOP at presentation (baseline) and at 1st month, 3rd months, 6th months
© Copyright 2025. All Rights Reserved by MedPath